SoftOx Solutions AS Logo

SoftOx Solutions AS

SOFTX | OL

Overview

Corporate Details

ISIN(s):
NO0010811961 (+2 more)
LEI:
549300AETMWJS91G4A50
Country:
Norway
Address:
Martin Linges vei 25, 1364 Fornebu
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

SoftOx Solutions AS is a clinical-stage pharmaceutical company developing a patented, non-toxic antimicrobial technology to address significant global health threats. The company's platform stabilizes a naturally occurring molecule (hypochlorous acid) to create highly effective solutions against a broad spectrum of pathogens, including bacteria, viruses, fungi, and biofilms. A key advantage of this technology is its mechanism of action, which does not contribute to the development of antimicrobial resistance (AMR). The company's primary focus includes an inhalation solution for airway infections, as well as products for advanced wound care and disinfection. SoftOx develops its technology in collaboration with leading scientific and clinical research institutions.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for SoftOx Solutions AS. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-03 12:39
Regulatory News Service
SoftOx Solutions AS: Investor Update in connection with the Refinement of the C…
English 1.6 MB
2025-09-03 12:39
Report Publication Announcement
SoftOx Solutions AS: Investor Update in connection with the Refinement of the C…
English 915 bytes
2025-09-02 08:59
ISS
SoftOx Solutions AS: Refines Clinical Focus and Advances Into Chronic Lung Dise…
Norwegian 8.7 KB
2025-08-26 14:35
Director's Dealing
SoftOx Solutions AS: Primary Insider Notification - Attachment: Skjema for meld…
Norwegian 125.5 KB
2025-08-26 14:35
Related Party Transaction
SoftOx Solutions AS: Primary Insider Notification - Attachment: Skjema for meld…
Norwegian 131.5 KB
2025-08-26 14:35
Director's Dealing
SoftOx Solutions AS: Primary Insider Notification - Attachment: Skjema for meld…
Norwegian 125.5 KB
2025-08-26 14:35
Director's Dealing
SoftOx Solutions AS: Primary Insider Notification
English 2.1 KB
2025-08-18 10:36
Share Issue/Capital Change
SoftOx Solutions AS: New Share Capital
English 1.6 KB
2025-08-14 22:02
Share Issue/Capital Change
SoftOx Solutions AS: Private Placement resolved
English 3.3 KB
2025-08-14 16:28
Capital/Financing Update
SoftOx Solutions AS: Softox Solutions secures committed financing facility
English 3.8 KB
2025-06-27 14:51
Board/Management Information
SoftOx Solutions AS: SoftOx Solutions AS appoints Dr. Tore Duvold as new board …
English 2.1 KB
2025-06-27 11:08
Post-Annual General Meeting Information
SoftOx Solutions AS: Minutes from the General Meeting - Attachment: SoftOx Solu…
English 497.1 KB
2025-06-27 11:08
Post-Annual General Meeting Information
SoftOx Solutions AS: Minutes from the General Meeting
English 352 bytes
2025-06-27 08:00
Quarterly Report
SoftOx Solutions AS: First Quarter Report 2025 - Attachment: SoftOx Solution_Q1…
English 911.0 KB
2025-06-27 08:00
Report Publication Announcement
SoftOx Solutions AS: First Quarter Report 2025
English 334 bytes

Automate Your Workflow. Get a real-time feed of all SoftOx Solutions AS filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SoftOx Solutions AS via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
TheraVet SA Logo Belgium ALVET
Thor Medical ASA Logo
Sustainably produces alpha-emitters from thorium for cancer therapies, without nuclear reactors.
Norway NANOV
Tikun Olam Cannbit Pharmaceuticals Ltd. Logo
Vertically integrated R&D and production of clinically-validated medical cannabis treatments.
Israel TKUN
TMS Co., Ltd Logo Japan 4891
Together Pharma Ltd. Logo
Researches and produces medical cannabis products for domestic and European patients.
Israel TGTR
Japan 4551
TOWA PHARMACEUTICAL CO.,LTD. Logo Japan 4553
TSUMURA & CO. Logo Japan 4540
TURK İLAÇ VE SERUM SANAYİ A.Ş. Logo
Turkish pharma producer of human medicines, vaccines, and high-capacity IV solutions (serum).
Türkiye TRILC
UCB Logo
UCB
A biopharmaceutical firm developing therapies for severe neurological and immunological diseases.
Belgium UCB